Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P2GU
|
|||
Former ID |
DIB008050
|
|||
Drug Name |
CSL-362-AML
|
|||
Drug Type |
Antibody
|
|||
Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1 | [1] | |
Company |
Janssen Biotech
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin 3 receptor alpha (IL3RA) | Target Info | . | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
PI3K-Akt signaling pathway | ||||
Apoptosis | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL3 Signaling Pathway | ||||
Pathway Interaction Database | IL3-mediated signaling events | |||
Reactome | GPVI-mediated activation cascade | |||
G beta:gamma signalling through PI3Kgamma | ||||
Interleukin-3, 5 and GM-CSF signaling | ||||
RAF/MAP kinase cascade | ||||
Interleukin receptor SHC signaling | ||||
WikiPathways | IL-3 Signaling Pathway | |||
Interleukin-2 signaling | ||||
Interleukin-3, 5 and GM-CSF signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031973) | |||
REF 2 | Monoclonal antibody targeting of IL-3 receptor alpha with CSL362 effectively depletes CML progenitor and stem cells. Blood. 2014 Feb 20;123(8):1218-28. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.